Analyst Steven Lichtman of Oppenheimer weighed in on ConforMIS Inc (NASDAQ:CFMS), after the medical device firm posted first-quarter earnings results. The company posted better than …
In a research report released Tuesday, Oppenheimer analyst Steven Lichtman maintained an Outperform rating on Sunshine Heart Inc (NASDAQ:SSH) and reduced the price …
In a research report issued yesterday, Oppenheimer analyst Steven Lichtman reiterated an Outperform rating on Medtronic (NYSE:MDT) and raised his price target to …
In a research report released Tuesday, Oppenheimer analyst Steven Lichtman maintained an Outperform rating on Macrocure Ltd. (NASDAQ:MCUR) with a price target of …
Oppenheimer analyst Steven Lichtman reaffirmed an Outperform rating on Integra Lifesciences (NASDAQ:IART) with a $57 price target, which represents a potential upside of …
In a research note issued today to investors, Oppenheimer analyst Steven Lichtman maintained an Outperform rating on Medtronic (NYSE:MDT) with a $73 price target, …
In a research note published today, analyst Steven Lichtman of Oppenheimer assigned an Outperform rating on Integra Lifesciences (NASDAQ:IART) with a $57 price target. Lichtman commented: “During our …
